Stock AKBA AKEBIA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Akebia Therapeutics, Inc.

Equities

AKBA

US00972D1054

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-07 pm EDT 		5-day change 1st Jan Change
1.4 USD -6.04% Intraday chart for Akebia Therapeutics, Inc. +11.11% +12.90%
Apr. 23 Averoa Seeks EU Approval for Chronic Kidney Disease Drug MT
Apr. 16 Akebia Therapeutics, Inc. and STA Pharmaceutical Hong Kong Limited Enters into Second Amendment to the Supply Agreement CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Akebia Therapeutics, Inc. Announces Management Changes, Effective March 22, 2024
CI
Akebia Therapeutics Names Nicholas Grund as Chief Commercial Officer
MT
Akebia Therapeutics Announces Appointment of Nicholas Grund as Chief Commercial Officer
CI
Akebia Therapeutics, Inc. Announces the Appointment of Richard C. Malabre as Chief Accounting Officer and Principal Accounting Officer
CI
Akebia Therapeutics, Inc. Announces Executive Changes
CI
Akebia Therapeutics Names Ellen Snow as Finance Chief
MT
Akebia Therapeutics, Inc. Announces Executive Changes
CI
Akebia Therapeutics, Inc. Announces Executive Changes
CI
Akebia Therapeutics, Inc. Appoints Ron Frieson to Its Nominating and Corporate Governance Committee
CI
Akebia Therapeutics, Inc. Appoints Ron Frieson to Board of Directors
CI
Immunic : Hires Patrick Walsh as Chief Business Officer
MT
Akebia Therapeutics, Inc. Announces Board Resignations
CI
Akebia Therapeutics Appoints LeAnne M. Zumwalt, Dialysis Industry Leader, to Board of Directors
CI
Akebia Therapeutics, Inc. Appoints Violetta Cotreau as Principal Accounting Officer
CI
Akebia Therapeutics Announces Executive Changes, Effective June 29, 2020
CI
Akebia Therapeutics, Inc. Announces Board Changes
CI
Akebia Therapeutics, Inc. Announces Resignation of Scott A. Canute as Class I Director
CI
Akebia Therapeutics, Inc. Announces Management Changes
CI
Akebia Therapeutics, Inc. Announces Board Changes
CI
Akebia Therapeutics, Inc. Announces Committee Appointments
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AKBA Stock
  4. News Akebia Therapeutics, Inc.
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW